Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients.
American Journal of Surgery
INTRODUCTION: Factors contributing to the use of preoperative MRI remain poorly understood.
METHODS: Data from a randomized controlled trial of stage 0-3 breast cancer patients undergoing breast conserving surgery between 2016 and 2018 were analyzed.
RESULTS: Of the 396 patients in this trial, 32.6% had a preoperative MRI. Patient age, race, ethnicity, tumor histology, and use of neoadjuvant therapy were significant predictors of MRI use. On multivariate analysis, younger patients with invasive lobular tumors were more likely to have a preoperative MRI. Rates also varied significantly by individual surgeon (p < 0.001); in particular, female surgeons (39.9% vs. 24.0% for male surgeons, p = 0.001) and those in community practice (58.9% vs. 14.2% for academic, p < 0.001) were more likely to order preoperative MRI. Rates declined over the two years of the study, particularly among female surgeons.
CONCLUSIONS: Preoperative MRI varies with patient age and tumor histology; however, there remains variability by individual surgeon.
Online ahead of print
Chagpar AB, Dupont E, Chiba A, Levine EA, Gass JS, Lum S, Brown E, Fenton A, Solomon NL, Ollila DW, Murray M, Gallagher K, Howard-McNatt M, Lazar M, Garcia-Cantu C, Walters L, Pandya S, Mendiola A, Namm JP; SHAVE2 authors. Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients. Am J Surg. 2021 Oct 23:S0002-9610(21)00620-6. doi: 10.1016/j.amjsurg.2021.10.028. Epub ahead of print. PMID: 34706816.